Inogen Announces Participation in the KeyBanc Life Sciences & MedTech Investor Forum

Rhea-AI Summary

Inogen, Inc. (NASDAQ: INGN), a medical technology company, announced its participation in the KeyBanc Life Sciences & MedTech Investor Forum. The presentation is scheduled for March 23, 2021, at 3:30 p.m. ET, featuring President and CEO Nabil Shabshab, and CFO Alison Bauerlein. Interested individuals can access the webcast on Inogen's Investor Relations page. The company emphasizes transparency by utilizing its website to disclose non-public material information in compliance with Regulation FD. Inogen develops innovative portable oxygen concentrators for patients with chronic respiratory conditions.

Positive

• Participation in the KeyBanc Life Sciences & MedTech Investor Forum can enhance visibility and investor interest.
• The webcast provides a platform for executives to communicate strategic objectives and company performance.

Negative

• None.

Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company’s management will be participating in the KeyBanc Life Sciences & MedTech Investor Forum.

Inogen’s President and CEO, Nabil Shabshab, and CFO, Alison Bauerlein, are scheduled to present on Tuesday, March 23^rd, 2021 at 3:30 p.m. ET. Interested parties can access the webcast from the News / Events section of the Investor Relations page on the Inogen website at www.inogen.com. A webcast replay will be available approximately one hour after the conclusion of the live presentation and will remain available for 90 days.

Inogen has used, and intends to continue to use, its Investor Relations website, http://investor.inogen.com/, as a means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD. For more information, visit http://investor.inogen.com/.

About Inogen

Inogen is a medical technology company offering innovative respiratory products for use in the homecare setting. Inogen primarily develops, manufactures, and markets innovative portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.

For more information, please visit www.inogen.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210312005003/en/

FAQ

When will Inogen present at the KeyBanc Life Sciences & MedTech Investor Forum?

Inogen will present on March 23, 2021, at 3:30 p.m. ET.

Who will represent Inogen at the KeyBanc Investor Forum?

Nabil Shabshab, President and CEO, and Alison Bauerlein, CFO, will represent Inogen.

Where can I find the webcast of Inogen's presentation?

The webcast can be accessed on Inogen's Investor Relations page at www.inogen.com.

What type of products does Inogen develop?

Inogen develops portable oxygen concentrators for supplemental long-term oxygen therapy.